FDA Warns oBand Centers About Website Marketing Materials

Posted on

The Marina Del Rey-based oBand Centers has been the recipient of a warning letter from the Food and Drug Administration which was issued in regard to the way the company promoted the Lap-Band procedure through marketing materials.  This isn’t the first time that the FDA has gotten involved in the promotion of the weight loss procedure.  2011 saw multiple warning letters issued to other businesses, and Lap-Band VIP was previously warned by the FDA because marketing materials failed to disclose potential dangers of the operation.  In the case of oBand Centers, the FDA alleges that their website doesn’t indicate risks and that a web video about the dangers is not sufficient due to its having small, illegible print that displays only briefly.

Click here to learn more about the warning.